EDGAR Filing Documents for 0001193125-14-247279

Form 8-K - Current report:

SEC Accession No. 0001193125-14-247279

Filing Date

2014-06-24

Accepted

2014-06-24 16:31:10

Documents

Period of Report

2014-06-18

Items

Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	d748341d8k.htm	8-K	32702
2	EX-99.1	d748341dex991.htm	EX-99.1	10623
3	GRAPHIC	g748341g03w67.jpg	GRAPHIC	25964
	Complete submission text file	0001193125-14-247279.txt		80777

Mailing Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628

Business Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628 609-359-3020

ANTARES PHARMA, INC. (Filer) CIK: 0001016169 (see all company filings)